PECAM1 and neoplasm: Additionally, the simultaneous detection of CD31, an endothelial marker, and increased NCL+ cells in NSCLC tissues is linked with lower DFS and higher recurrence risk, particularly in stage I patients with smaller tumours and those undergoing surgery.12